SG11201702666SA - Inhalation device - Google Patents

Inhalation device

Info

Publication number
SG11201702666SA
SG11201702666SA SG11201702666SA SG11201702666SA SG11201702666SA SG 11201702666S A SG11201702666S A SG 11201702666SA SG 11201702666S A SG11201702666S A SG 11201702666SA SG 11201702666S A SG11201702666S A SG 11201702666SA SG 11201702666S A SG11201702666S A SG 11201702666SA
Authority
SG
Singapore
Prior art keywords
inhalation device
inhalation
Prior art date
Application number
SG11201702666SA
Inventor
Nenad Bencic
Original Assignee
Xellia Pharmaceuticals Aps
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Xellia Pharmaceuticals Aps filed Critical Xellia Pharmaceuticals Aps
Publication of SG11201702666SA publication Critical patent/SG11201702666SA/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M11/00Sprayers or atomisers specially adapted for therapeutic purposes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M11/00Sprayers or atomisers specially adapted for therapeutic purposes
    • A61M11/001Particle size control
    • A61M11/003Particle size control by passing the aerosol trough sieves or filters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Biomedical Technology (AREA)
  • Anesthesiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Dispersion Chemistry (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Otolaryngology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Manipulator (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SG11201702666SA 2014-10-03 2015-10-01 Inhalation device SG11201702666SA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201462059748P 2014-10-03 2014-10-03
PCT/EP2015/072736 WO2016050933A1 (en) 2014-10-03 2015-10-01 Inhalation device

Publications (1)

Publication Number Publication Date
SG11201702666SA true SG11201702666SA (en) 2017-04-27

Family

ID=54249495

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201702666SA SG11201702666SA (en) 2014-10-03 2015-10-01 Inhalation device

Country Status (26)

Country Link
US (1) US11033602B2 (en)
EP (2) EP3520777B1 (en)
JP (1) JP6626890B2 (en)
KR (1) KR102494511B1 (en)
CN (1) CN106999542B (en)
AU (1) AU2015326847B2 (en)
BR (1) BR112017006816A2 (en)
CA (1) CA2962120C (en)
CO (1) CO2017004442A2 (en)
CY (1) CY1121803T1 (en)
DK (1) DK3200762T3 (en)
ES (1) ES2721401T3 (en)
HR (1) HRP20190747T1 (en)
HU (1) HUE044289T2 (en)
IL (1) IL251480B (en)
LT (1) LT3200762T (en)
MX (1) MX2017004175A (en)
PH (1) PH12017500538A1 (en)
PL (1) PL3200762T3 (en)
PT (1) PT3200762T (en)
RS (1) RS58792B1 (en)
RU (1) RU2702335C2 (en)
SG (1) SG11201702666SA (en)
SI (1) SI3200762T1 (en)
TR (1) TR201906108T4 (en)
WO (1) WO2016050933A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL3200827T3 (en) 2014-10-03 2020-12-14 Xellia Pharmaceuticals Aps Compositions
CN112546030A (en) * 2019-09-26 2021-03-26 盈科瑞(天津)创新医药研究有限公司 Polymyxin E sodium methanesulfonate solution for inhalation and preparation method thereof
US20230052317A1 (en) * 2021-08-05 2023-02-16 Zambon S.P.A. Treatment of non-cystic fibrosis bronchiectasis

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1062895A (en) 1962-12-13 1967-03-22 Wellcome Found Sulphomethyl derivatives of polymxin
FR1586834A (en) 1968-02-12 1970-03-06
DE1906699A1 (en) 1968-02-12 1970-02-05 Pfizer Antibiotic polymyxin methane sulphonic acid
AU611030B2 (en) 1988-04-07 1991-05-30 Edward Shanbrom Non-thrombogenic intravascular time release catheter
SE9201246D0 (en) 1992-04-21 1992-04-21 Kabi Pharmacia Ab INJECTION CARTRIDGE ARRANGEMENT
NL9401260A (en) 1993-11-12 1995-06-01 Cornelis Johannes Maria Van Ri Membrane for microfiltration, ultrafiltration, gas separation and catalysis, method for manufacturing such a membrane, mold for manufacturing such a membrane, as well as various separation systems comprising such a membrane.
WO1998020836A2 (en) 1996-11-15 1998-05-22 Pathogenesis Corporation Pure biologically active colistin, its components and a colistin formulation for treatment of pulmonary infections
US5767068A (en) * 1997-02-13 1998-06-16 Pathogenesis Corporation Pure biologically active colistin, its components and a colistin formulation for treatment of pulmonary infections
PT1320355E (en) 2001-05-18 2006-08-31 Chiron Corp SYSTEM FOR ADMINISTRATION OF AN TOBRAMYCIN FORMULATION
US20040022740A1 (en) 2001-07-10 2004-02-05 Baker William R. Macrolide formulations for inhalation and methods of treatment of endobronchial infections
SI1340506T1 (en) 2002-03-01 2007-04-30 Chiesi Farma Spa Compositions comprising pulmonary surfactants and a polymyxin having improved surface properties
WO2008025560A1 (en) * 2006-09-01 2008-03-06 Pari Pharma Gmbh Methods for taste masking of nebulised compositions for nasal and pulmonary inhalation therapy
US20080066739A1 (en) * 2006-09-20 2008-03-20 Lemahieu Edward Methods and systems of delivering medication via inhalation
US8329645B2 (en) * 2008-02-08 2012-12-11 Northern Antibiotics Ltd. Polymyxin derivatives and uses thereof
DE102008030267B3 (en) 2008-06-19 2010-01-28 Arzneimittel Gmbh Apotheker Vetter & Co. Ravensburg Method for filling dual-chamber systems in pre-sterilizable carrier systems and pre-sterilisable carrier system
WO2011043712A1 (en) 2009-10-08 2011-04-14 Shl Group Ab Metered liquid droplet inhaler
AU2010311759B2 (en) 2009-10-30 2015-09-24 Xellia Pharmaceuticals Aps Method for purification of colistin and purified colistin components
WO2012168820A1 (en) 2011-06-08 2012-12-13 Pfizer Inc. Polymyxin derivatives useful as antibacterial agents
CN102531955B (en) 2011-09-16 2014-02-19 浙江众益制药股份有限公司 Preparation method of olsalazine disodium and postprocessing method of methyl sulfonation reaction
KR20150107793A (en) 2013-01-11 2015-09-23 셀리아 파마슈티칼즈 에이피에스 Compositions, methods of making and methods of use
TW201522364A (en) 2013-06-07 2015-06-16 Xellia Pharmaceuticals Aps Characterization of colistimethate sodium (CMS)
BR112017000228A2 (en) 2014-07-09 2017-10-31 Xellia Pharmaceuticals Aps low substitution polymyxins and their compositions.
PL3200827T3 (en) * 2014-10-03 2020-12-14 Xellia Pharmaceuticals Aps Compositions

Also Published As

Publication number Publication date
EP3200762A1 (en) 2017-08-09
US20190022171A1 (en) 2019-01-24
US11033602B2 (en) 2021-06-15
JP6626890B2 (en) 2019-12-25
HUE044289T2 (en) 2019-10-28
CY1121803T1 (en) 2020-07-31
RU2017114144A (en) 2018-11-06
TR201906108T4 (en) 2019-05-21
KR20170062521A (en) 2017-06-07
AU2015326847B2 (en) 2018-11-29
CA2962120C (en) 2023-09-19
MX2017004175A (en) 2017-08-28
RS58792B1 (en) 2019-07-31
CA2962120A1 (en) 2016-04-07
KR102494511B1 (en) 2023-01-31
DK3200762T3 (en) 2019-05-06
PT3200762T (en) 2019-05-28
EP3200762B1 (en) 2019-03-27
CN106999542A (en) 2017-08-01
PH12017500538A1 (en) 2017-08-07
LT3200762T (en) 2019-06-10
JP2017530138A (en) 2017-10-12
WO2016050933A1 (en) 2016-04-07
CN106999542B (en) 2021-02-02
SI3200762T1 (en) 2019-08-30
HRP20190747T1 (en) 2019-07-12
RU2702335C2 (en) 2019-10-08
AU2015326847A1 (en) 2017-04-13
PL3200762T3 (en) 2019-08-30
RU2017114144A3 (en) 2019-04-17
ES2721401T3 (en) 2019-07-31
EP3520777A1 (en) 2019-08-07
CO2017004442A2 (en) 2017-09-29
IL251480A0 (en) 2017-05-29
EP3520777B1 (en) 2020-09-30
BR112017006816A2 (en) 2018-01-09
IL251480B (en) 2019-09-26

Similar Documents

Publication Publication Date Title
GB201405937D0 (en) Inhalation device
HK1245056A1 (en) Intubation device
IL251572A0 (en) Aerosol-generating device
PT3110483T (en) Inhaler
EP3126132C0 (en) Embossing-laminating device
ZA201603150B (en) Inhaler device
AP2016009515A0 (en) Inhaler device
GB201505882D0 (en) Inhalation device
ZA201608603B (en) Inhalation device
GB201417883D0 (en) Rat-trapping device
GB201420436D0 (en) Device
IL251480A0 (en) Inhalation device
GB201411628D0 (en) Device
AU358579S (en) Inhaler
GB201419857D0 (en) Device
TWM490602U (en) Extending device
GB201515548D0 (en) Breathing device
PT2923679T (en) Nasal device
HUP1400248A2 (en) Respiration improving device
GB201420106D0 (en) Frenotomy device
GB201416453D0 (en) Device
GB201416454D0 (en) Device
GB201416455D0 (en) Device
GB201416457D0 (en) Device
GB201411954D0 (en) Device